![]() |
|
|
Vol. 17, Issue 10, 4200-4211, October 2006
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Department of Physiology, University of Maryland, School of Medicine, Baltimore, MD 21201
Submitted February 13, 2006;
Revised June 20, 2006;
Accepted July 6, 2006
Monitoring Editor: Keith Mostov
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
Orthologues of this C. elegans PDZ protein complex have been identified in mammalian tissues (Borg et al., 1998
; Butz et al., 1998
; Straight et al., 2001
b; Olsen et al., 2002
). Although renal epithelia do not express a Lin-10 orthologue (Borg et al., 1998
), the mLin-7 and CASK complex is evolutionarily conserved and localizes exclusively at the basolateral membrane (Olsen et al., 2005
; Straight et al., 2001
). Recently, we demonstrated that mLin-7 binds the inwardly rectifying potassium channel Kir 2.3 through a PDZ interaction and that the mLin-7/CASK complex plays an important role in coordinating polarized expression of the channel at the basolateral membrane by preventing the channel from traveling in the endocytic pathway (Olsen et al., 2002
). The mLin-7/CASK complex has also been implicated in basolateral expression of the epithelial GABA transporter BGT-1 (Perego et al., 1999
), the EGF-like receptor ErbB-2/Her2 (Shelly et al., 2003
), and other potassium channels (Leonoudakis et al., 2004b
), suggesting that interaction with the mLin-7/CASK complex represents a general mechanism for the polarized expression of basolateral membrane proteins containing a PDZ-binding motif.
While investigating the mechanism for polarized expression of Kir 2.3, we discovered a novel PDZ-binding partner for the channel, Tax-interacting Protein-1 (TIP-1). A partial TIP-1 clone was originally identified through a yeast two-hybrid screen as one of many binding partners for the viral oncoprotein Tax (Rousset et al., 1998
). Here, we show that the full-length TIP-1 encodes a protein consisting of a single PDZ domain and appears to be devoid of other proteinprotein interaction modules. This represents a departure from the classic PDZ protein retention/clustering scheme because PDZ proteins rely on multiple proteinprotein interaction motifs to effectively scaffold membrane, cytoskeletal, and signaling proteins. Indeed, TIP-1 antagonizes the retention function of the mLin-7/CASK complex by competing for interaction with Kir 2.3. This molecular switch results in internalization of Kir 2.3 channels. The competitive PDZ interaction described here represents a novel mechanism for regulating the surface expression of Kir 2.3 channels and may provide a more general means for regulating other PDZ protein interactions.
| MATERIALS AND METHODS |
|---|
|
|
|---|
ONPG Solution
-galactosidase Assay
-galactosidase activity was measured at Vmax using 2-nitrophenyl-
-D- galactopyranoside (ONPG), according to established methods (Mendelsohn and Brent, 1994
). Transfected yeast were grown (A600 of 0.91.2) under conditions that induce or repress the promoter. Yeast cultures were pelleted then resuspended in buffer and diluted 1:10 in buffer containing 0.001% SDS and 2% chloroform. Tubes were equilibrated at 30°C (15 min), and ONPG was added. The reaction was stopped with 1 M Na2CO3, and product was measured by spectrofluorometry. Miller units were calculated as previously described (Reynolds et al., 1997
).
Antibodies
Anti-TIP-1 antibodies were raised in rabbits against a unique epitope in TIP-1 (39-DQDPSQNPFSEDKTC) and affinity-purified. The epitope is conserved across mammalian species, including dog (Supplementary Data I). Anti-Kir 2.3 antibody was previously described (Olsen et al., 2002
). Because the Kir 2.3 immunogen is not available, preimmune serum of matched IgG concentration was used as a control for the Kir 2.3 localization studies. All other antibodies were purchased from commercial suppliers: rabbit anti-His, rabbit anti-myc, and mouse anti-myc (9E10; Santa Cruz Biotechnologies, Santa Cruz, CA); mouse anti-FLAG M2 and anti-VSV monoclonal antibodies (Sigma, St. Louis, MO); mouse anti-CASK and anti-NaK/ATPase
1 (Upstate Cell Signaling Solutions, Waltham, MA); rabbit anti-Veli3 (aka Lin-7C; Zymed Laboratories, South San Francisco, CA); mouse anti-HA (Boehringer Mannheim, Indianapolis, IN); rabbit anti-Rab11 (BD Transduction Laboratories, Lexington, KY); horseradish peroxidase (HRP)-conjugated goat anti-mouse (Jackson Laboratory, Bar Harbor, ME); HRP-conjugated goat anti-Rabbit and mouse anti-GST (Amersham Biosciences, Piscataway, NJ); AlexaFluor-conjugated secondary antibodies (Molecular Probes, Eugene, OR).
DNA Constructs
FLAG and myc epitope tags were engineered into the N- or C- terminus of TIP-1, respectively, by PCR and subcloned into the pcDNA3.1 vector for cell studies or into the pShuttleCMV vector (Stratagene, La Jolla, CA) for creation of adenoviral constructs. Mutagenesis was done by PCR with PfuTubo DNA polymerase (QuikChange, Stratagene). All sequences were verified by dye termination DNA sequencing. Methods for the construction of the Kir 2.3 COOH-terminal lexA fusions and the VSV(Y2F form)-tagged wild-type Kir 2.3 have been described previously (Le Maout et al., 2001
; Olsen et al., 2002
).
Synthesis of Recombinant Proteins
FLAG-tagged full-length TIP-1 cDNAs were subcloned into the pRSET vector (Invitrogen) in-frame with an N-terminal His-tag to produce pRSET-TIP-1/WT, K20A, H90A, and K20A/H90A double mutant. The final 25 residues of the C-terminal tail of WT and
PDZ Kir 2.3 were subcloned into the pGEX 5x-1 vector (Amersham) in-frame with an N-terminal GST tag to produce pGEX-Kir 2.3 and -Kir 2.3
PDZ. These expression vectors were transformed into BL21(DE3)pLysS (Invitrogen) competent Escherichia coli. Recombinant His-TIP-1 proteins were purified using Ni-NTA spin columns (Qiagen, Chatsworth, CA). Recombinant GST-Kir 2.3 proteins were purified using GS4B-sepharose (Amersham) and dialyzed against PBS. Total protein concentration was determined by Bradford Assay.
GST Pulldown
GST-Kir 2.3 and GST-Kir 2.3
PDZ were incubated with GS4B beads for 1 h, washed with PBS, and incubated overnight with recombinant His-TIP-1. Beads were washed with TEE (50 mM Tris-HCl, pH 7.5), 1 mM EDTA, 1 mM EGTA) and then eluted by boiling in SDS-sample buffer.
Northern Analysis
Northern blot derived from multiple human tissues (Origene, Rockville, MD) containing 2 µg poly(A)-RNA per lane was probed with a 591-base pair cDNA fragment of TIP-1 (bases 400991) and labeled by random priming with [
-32P]dCTP (Amersham) according to manufacturer's instructions (Boehringer Mannheim). The blot was stripped and reprobed with [
-32P]dCTP-labeled human
-actin cDNA fragment as a control for loading.
Cell Culture and Transfection
All mammalian cell lines were cultured in a humidified atmosphere at 37°C in 5% CO2. COS, HEK, and type II MDCK cells were cultured as previously described (Olsen et al., 2002
). Cells were transfected using LipofectAMINE transfection reagent (Invitrogen). Transfection medium was replaced 24 h after transfection with maintenance medium supplemented with 2 mM sodium butyrate (Sigma). The MDCK/TIP-1-myc stable cell line was created by a neomycin-selection protocol as previously described (Le Maout et al., 1997
).
Production of TIP-1 Adenoviruses
Adenoviral vectors containing wild-type and H90A C-myc-TIP-1 were produced using AdEasy Adenoviral Vector System according to manufacturer's instructions (Stratagene). After viral amplification in low passage HEK cells, virus was harvested in Dulbecco's phosphate-buffered saline containing 1 mM MgCl2 (DPBS-M, Sigma) and purified on a cesium chloride gradient. The viral band was then loaded onto a PD-10 column (Amersham) to remove cesium chloride and eluted in DPBS-M.
Adenoviral Infection of MDCK-Kir 2.3VSV Cells
MDCK/Kir2.3-VSV cells were plated 1.5 x 105 cells/well on 12-mm-diameter Transwell polycarbonate filters (0.4-µm pore size, Corning Costar, Corning, NY) 2448 h before infection. A "calcium switch" infection protocol was used as previously described (Henkel et al., 1998
). Briefly, wells were filled with DPBS-M one time to wash, refilled with DPBS-M, and incubated for 1530 min at 37°C and 5% CO2. Purified adenovirus was added to the apical chamber at an MOI of 100 while DPBS-M was added to the basolateral chamber. Mock-infected cells were treated identically, except that virus was omitted during the incubation period. Cells were incubated 12 h at 37°C and 5% CO2 before replacing complete growth medium in both the apical and basolateral chambers. Cells were incubated for 26 h after infection to permit protein expression. Epithelial integrity and cell confluence were assessed by transepithelial resistance measurements (EVOHM, WPI).
Cell Lysis
COS cells were lysed as described previously (Olsen et al., 2002
). Adenovirus-infected MDCK/Kir 2.3-VSV cells were washed twice in ice-cold Ringer's solution (5 mM HEPES, 144 mM NaCl, 5 mM KCl, 1.2 mM NaH2PO4, 5.5 mM glucose, 1 mM MgCl2, 1 mM CaCl2, pH 7.4), harvested in ice-cold HEENG buffer (20 mM HEPES, pH 7.6, 25 mM NaCl, 1 mM EDTA, 1 mM EGTA, 10% glycerol; Leonoudakis et al., 2004b
), and resuspended in HEENG containing 1.0% Triton and protease inhibitors. Both COS and MDCK/Kir 2.3-VSV cell lysates were then passed though a 27-gauge needle, rotated at 4°C for 1 h, and centrifuged at max speed to pellet insoluble material. Protein concentrations were assessed by Bradford Assay Reagent (Bio-Rad, Richmond, CA).
Rat Kidney Homogenization
Isolated whole kidneys were resuspended in TSE buffer (20 mM Tris, 150 mM NaCl, 5 mM EDTA, pH 7.5) containing protease inhibitor cocktail and homogenized using a glass tissue homogenizer.
Immunoprecipitation and Immunoblotting
Cell lysates were precleared with Sepharose B (Sigma) or Fast Flow protein A Sepharose (Sigma) for 2 h at 4°C. The supernatants were than rotated overnight at 4°C with appropriate antibody and protein A. Beads were washed three times with lysis buffer containing 0.1% Triton and then eluted for 30 min at room temperature (RT) with SDS sample buffer. Eluates were separated by SDS-PAGE and transferred to nitrocellulose (Amersham). Membranes were probed with appropriate primary and HRP-conjugated secondary antibodies and developed with SuperSignal West Pico Chemiluminescent Substrate (Pierce Chemical, Rockford, IL). Densitometric measurements were made using NIH image software.
In Vitro TIP-1/Lin-7 Competition Binding
VSV-Kir 2.3/Lin 7 was recovered from COS cells cotransfected with VSV-Kir 2.3 and HA-Lin 7 (50 µl cell lysate,
4x cell volume) using anti-VSV antibodies (3 µg) bound to protein G-Sepharose after incubation overnight at 4°C. Subsequently, lysates from COS cells, which were separately transfected with vector (pcDNA) or myc-TIP-1 cDNA, were prepared and incubated with the immunopurified VSV-Kir 2.3/Lin 7 on anti-VSV protein G beads. Three different lysates were compared: 1) pcDNA alone (100 µl); 2) a mixture of equal volumes of vector (50 µl) and myc-TIP-1 (50 µl), and 3) myc-TIP-1 alone (100 µl). After the incubation, immunoprecipitates were washed, eluted, and immunoblotted as described above.
Surface Biotin Labeling
MDCK/Kir 2.3-VSV cells, grown on filters, were placed on ice and washed twice with ice-cold Ringer's solution. Impermeable NHS-SS-biotin (Pierce; 1.5 mg/ml) in Ringer's was added to the basolateral compartment. Cells were incubated for 30 min at 4°C, before quenching by incubation with 50 mM Tris-HCl (pH 7.5) in Ringer's for 30 min at 4°C. Cells were immediately fixed and permeabilized as described below. AlexaFluor-conjugated streptavidin was added to secondary antibody solution to visualize biotin labeling.
Immunocytochemistry
Cells were washed twice with ice-cold Ringer's and then fixed in 3% paraformaldehyde for 15 min at 4°C. Adenovirus-infected MDCK/Kir2.3-VSV cells were permeabilized/blocked for 1 h at RT with 0.4% saponin and 1.0% BSA in Ringer's solution, and 0.4% saponin was subsequently included in all wash and antibody solutions. For all other experiments, cells were permeabilized in 0.1% Triton X-100 for 30 min at 4°C, washed in ice-cold Ringer's, and blocked for 15 min at RT in 1.0% BSA. Next, cells were incubated overnight at 4°C with the primary antibodies, washed, and then incubated with appropriate AlexaFluor-conjugated secondary antibodies (Molecular Probes). Labeled cells were mounted onto slides with VectaShield glycerol mounting medium (Vector Laboratories, Burlingame, CA) and sealed with nail polish.
Fixation of male 129/SvEv mouse and Sprague Dawley rat kidneys was achieved by arterial perfusion. PBS was perfused 2 min before 30-min perfusion with paraformaldehyde (2%) and a 2-min perfusion with a cryoprotectant (10% EDTA in 0.1 M Tris). Kidney sections (12 µm) were cut with a cryostat, placed on HistoGrip-coated coverslips (Zymed), and stored at 80°C. To perform immunolocalization, sections were first rehydrated with PBS and then treated with 0.5% SDS to unmask protein epitopes. Kidney sections were then washed three times in a high-salt buffer (PBS containing 1% BSA and 385 mM NaCl), blocked (PBS containing 1% BSA and 50 mM glycine), and incubated overnight with primary antibodies (10 µg/µl) at 4°C in PBS supplemented with 0.1% BSA and 0.02% NaN3. Samples were washed in high-salt buffer and incubated with AlexaFluor-488 conjugated goat anti-rabbit secondary antibodies amplified by an additional 2-h incubation with donkey anti-goat Alexa488 before washing and mounting in VectaShield medium.
Imaging Studies
To determine cellular localization of proteins, cells were visualized using the Zeiss 410 confocal laser-scanning microscope (Carl Zeiss, Thornwood, NY) under a 63x oil immersion lens (NA = 1.40). Images were processed with Adobe Photoshop (San Jose, CA).
To assess intracellular expression of Kir 2.3 in stable TIP-1+ MDCK cells and after adenoviral mediated delivery of TIP-1 constructs into MDCK cells stably expressing Kir 2.3, images of cells were scored for intracellular localization of Kir 2.3 (2 = strong, 1 = moderate, 0 = none) by an observer who was blinded to knowledge of the treatment groups. In the adenoviral experiments, cells were colabeled with anti-VSV antibodies to detect Kir 2.3, with streptavidin to mark the basolateral membrane and anti-myc antibodies to detect myc-TIP-1infected cells. In all cases, only cells that costained positively for TIP-1 protein expression were scored. Scores for equal numbers of cells from three separate experiments were pooled and then averaged together to produce an "Intracellular Localization Score" for each experimental condition.
Statistical Analysis
Statistical significance was calculated by one-way randomized ANOVA followed by Dunnett's post hoc test. p < 0.05 was considered significant.
| RESULTS |
|---|
|
|
|---|
|
|
The simple structure of TIP-1 predicts that it would function as a negative regulator of PDZ complexes. Interaction of Kir 2.3 with TIP-1 is predicted to displace the channel from the mLin-7/CASK complex and consequently induce endosomal targeting. Here we test this hypothesis.
Coimmunoprecipitation of TIP-1 and Kir 2.3
As an initial test of the scaffolding antagonist function, we verified that TIP-1 interacts with Kir 2.3 in mammalian cells using coimmunoprecipitation analysis. For this purpose, the N-termini of Kir 2.3 and TIP-1 were engineered with the VSV G protein epitope and FLAG tag, respectively. Transfection of COS cells with these constructs results in expression of the predicted proteins as detected by immunoblot analysis; anti-FLAG antibodies specifically detected a 16-kDa protein, corresponding to FLAG-tagged TIP-1 (Figure 3A), and anti-VSV antibodies recognize a 59-kDa band, corresponding to VSV-Kir 2.3 (Figure 3B, lane 2). The Kir 2.3 channel could be specifically coimmunoprecipitated with TIP-1 from COS cells cotransfected with VSV-Kir 2.3 and Flag-TIP-1, using anti-FLAG antibodies (Figure 3B, lane 5). As controls, the FLAG antibody failed to immunoprecipitate cells transfected with VSV-Kir 2.3 alone (Figure 3B, lane 4). Immunoprecipitation of the VSV-Kir 2.3 channel with FLAG-TIP-1 also required the FLAG antibody; reactions without antibody (Figure 3B, lane 3) or with a control rabbit antibody (Figure 3B, lane 6) did not immunoprecipitate VSV-Kir 2.3 from COS cells cotransfected with VSV-Kir 2.3 and FLAG-TIP-1. Collectively, these results establish that the full-length TIP-1 is capable of interacting with full-length Kir 2.3 in mammalian cells.
|
-galactosidase). Counting from the extreme C-terminal amino acid of Kir 2.3, residues at positions 0, -2, and -3 were found to be absolutely required for interaction with TIP-1, indicative of a type I PDZ interaction (Songyang et al., 1997
|
PDZ, residues L416-I441), as a negative control. As shown in Figure 4C, wild-type TIP-1 interacted with wild-type GST-Kir 2.3, confirming that the interaction between the two proteins is direct and requires no additional protein mediators (Figure 4C). In agreement with the yeast two-hybrid data, GST-Kir 2.3
PDZ failed to bind to wild-type TIP-1 protein, further verifying that interaction requires the PDZ ligand motif in Kir 2.3. As expected for a PDZ domain interaction, binding was significantly abrogated by the single mutations of K20A or H90A or by the double mutation, confirming that this interaction is mediated through the TIP-1 PDZ domain (Figure 4, C and D).
TIP-1 Can Compete with mLin-7 for Kir 2.3 Interaction
Our observations that TIP-1 binds to Kir 2.3 in a PDZ-dependent manner suggest that TIP-1 could potentially compete with the basolateral scaffolding protein, mLin-7, for channel interaction. To test this idea directly, in vitro competition binding assays were performed (Figure 5A). In these studies, Kir 2.3-mLin-7 complexes were recovered on protein G-Sepharose beads with anti-VSV antibodies from COS cells expressing VSV-tagged Kir 2.3 and HA-tagged mLin-7. Beads were then incubated at RT for 3 h with COS lysates containing either myc-tagged TIP-1 or vector (pcDNA). To assess the relative extent of channel interaction with myc-TIP-1 and HA-mLin-7, the Kir 2.3 precipitates were resolved by SDS-PAGE and immunoblotted with either anti-myc or anti-HA antibodies. As shown in Figure 5B and summarized in Figure 5C (n = 3), addition of the TIP-1 lysate reduced the amount of mLin-7 associated with Kir 2.3 in a concentration-dependent manner (Figure 5B, top panel). This was paralleled by an increase in TIP-1 binding to the channel (Figure 5B, bottom panel). Thus, TIP-1 has the capacity to uncouple Kir 2.3 from the mLin-7/CASK protein scaffold.
|
|
|
Figure 8A shows the effects of wild-type TIP-1 and the H90A mutant TIP-1 on Kir 2.3 channel localization in representative MDCK monolayers stably expressing the channel. Quantitative evaluations of three separate infections are summarized in Figure 8B. Expression of the wild-type TIP-1 caused Kir 2.3 to distribute into an intracellular vesicular compartment (Figure 8A, middle panel). By contrast, the TIP-1(H90A) mutant protein did not produce a significant change in channel localization (Figure 8A, right panel). The extent and percentage (25% of mock, 96% of TIP-1, and 39% of H90A TIP-1expressing cells exhibit significant intracellular localization) of wild-type TIP-1expressing cells exhibiting intracellular localization of Kir 2.3 in these studies is remarkably similar to the results with the stable TIP-1+ MDCK cells.
|
1 (Figure 8C), demonstrating that TIP-1 does not cause a global disruption of basolateral membrane traffic. Together, these observations indicate that TIP-1 alters steady-state localization of Kir 2.3 in a PDZ-dependent manner, consistent with a PDZ scaffolding antagonist.
TIP-1 Uncouples Kir 2.3 from the Basolateral mLin-7/CASK Complex
To test whether TIP-1 induces mistrafficking of Kir 2.3 by uncoupling the channel from the mLin-7 scaffolding protein, we measured the extent of mLin-7/Kir 2.3 interaction in Kir 2.3VSV+MDCK cells after adenoviral-mediated delivery of TIP-1. The effects of wild-type TIP-1 and the H90A TIP-1 mutant were compared. In these studies, endogenous mLin-7 was immunoprecipitated with an anti-mLin-7 antibody and the amount of coimmunoprecipitated Kir 2.3 and CASK were assessed by immunoblotting. As shown in Figure 9A, infection with wild-type TIP-1, but not the H90A mutant, reduced the amount of mLin-7 associated with Kir 2.3 without affecting mLin-7/CASK association. Densitometric measurements of immunoblots from three separate experiments verified that the effect is consistent and statistically significant (Figure 9B). These data provide strong evidence that TIP-1 can prevent association of Kir 2.3 with mLin-7/CASK without altering the integrity of the basolateral membrane scaffold complex.
|
| DISCUSSION |
|---|
|
|
|---|
Our study suggests that TIP-1 may normally operate as a natural "dominant negative" PDZ protein. This would represent the first example of a PDZ protein antagonist and expand an emerging biological paradigm of naturally "fractured" (Kroiher et al., 2001
) or truncated molecules that function in a wide variety of biological processes as negative modulators. For instance, transcription by basic helix-loop-helix (bHLH) transcription factors are negatively regulated by "broken" mimics of themselves that contain a bHLH domain but lack a DNA-binding domain necessary for transcriptional activity (Yokota and Mori, 2002
). Similarly, decoy receptors of the tumor necrosis factor receptor superfamily contain the extracellular ligand-binding domain but lack intracellular domains required for effective signaling (Khosla, 2001
; Mantovani et al., 2004
). Similar examples of "natural dominant negatives" can be found among structural proteins; the neuronal gene product, Homer1a, provides an elegant example. Proper signaling by type I metabotropic glutamate receptors (mGluRs) requires association with self-multimerizing Homer proteins (Xiao et al., 1998
; Ango et al., 2001
). Homer1a lacks a conserved coiled-coil domain necessary for the multimerization process, and thus up-regulation of endogenous Homer1a by excitotoxic brain injury results in decreased association of other Homer proteins with mGluRs and disregulated signaling by the receptor (Ango et al., 2001
). Each of the negative modulators described above lacks a structural module critical to the normal functioning of typical proteins within the family. TIP-1 is no exception; it is composed almost entirely of a single PDZ domain and lacks any other obvious proteinprotein interaction modules.
Unlike TIP-1, typical PDZ proteins contain multiple proteinprotein interaction modules, allowing them to act as macromolecular scaffolds (Kim and Sheng, 2004
; Brone and Eggermont, 2005
). The basolateral scaffolding function of mLin-7, for example, is made possible by the presence of its two different proteinprotein interaction modules. mLin-7 interacts with target proteins, such as Kir 2.3, via a PDZ interaction (Olsen et al., 2002
), while simultaneously binding to CASK via a heterotypic L27 domain interaction (Borg et al., 1998
; Straight et al., 2000
). CASK, in turn, associates with the basolateral membrane through a web of interactions, forming a multimeric complex that has the capacity to act as a stable basolateral membrane anchor. Indeed, multiple proteinprotein interactions sites allow CASK to simultaneously bind to mLin-7, extracellular matrix receptors, adhesion molecules, and the actin cytoskeleton (Cohen et al., 1998
). SAP97, another Kir 2.3 PDZ-binding partner, also interacts with CASK (Leonoudakis et al., 2001
) through an independent L27 domain interaction (Karnak et al., 2002
; Lee et al., 2002
; Roh et al., 2002
). The mLin-7 and SAP97 L27 domains separately assemble with the two L27 domains of CASK, possibly as a dimer of L27 heterodimers (Feng et al., 2004
; Li et al., 2004
), to form a mLin-7/SAP97/CASK complex (Leonoudakis et al., 2004b
). Our studies indicate that TIP-1 disrupts Kir 2.3 interaction with mLin-7 without altering the mLin-7/CASK complex.
Dominant negative mLin-7 mutants, lacking their L27 domain (mLin-7-
L27), also behave like TIP-1. Removal of the L27 domain in mLin-7 disrupts CASK association, causing a cytoplasmic localization pattern that is identical to TIP-1 (Straight et al., 2000
). Similar effects have been observed with SAP97 mutants, lacking their L27 domain (Roh et al., 2002
). Shelly et al. (2003)
showed that expression of mLin-7-
L27 mutants alters basolateral membrane targeting of a mLin-7 PDZ-binding partner, ErbB-2, in MDCK cells, reminiscent of the effects observed here with TIP-1 on Kir 2.3. Similarly, expression of a dominant negative CASK construct that contains both L27 domains but no basolateral membrane localization determinants causes a related mLin-7 binding partner, Kir 2.2, to mislocalize into a vesicular compartment in MDCK cells (Leonoudakis et al., 2004a
, 2004b
). Without L27 domains, neither mLin-7 nor SAP97 can bridge their PDZ-binding target proteins to CASK and the basolateral membrane. TIP-1 only contains a PDZ-binding domain, and consequently it produces similar mistargetting defects as engineered dominant-interfering PDZ constructs.
TIP-1 appears to be well suited for its role as a natural dominant-negative PDZ protein. First, we found that TIP-1 is constitutively expressed in many tissues and is especially enriched in epithelia, suggesting that there is sufficient copy number to compete with PDZ-based scaffolding proteins, such as mLin-7. In principal cells of the renal collecting duct TIP-1 is expressed as a cytoplasmic protein, consistent with it acting as a physiologically relevant PDZ scaffold antagonist in the epithelial cells where Kir 2.3 is found. Second, we have demonstrated by competitive coimmunoprecipitation that TIP-1 can successfully vie with mLin-7 for access to the C-terminal PDZ ligand of Kir 2.3, suggesting that TIP-1 has adequate binding affinity for the substrate to compete successfully with PDZ-protein scaffolds. It is left to future studies to determine whether TIP-1 abundance or binding affinity is physiologically regulated.
The subcellular locale where TIP-1 exerts its dominant negative effects also remains to be precisely identified. Although it is well established that the mLin-7/CASK complex stabilizes mLin-7 target proteins at the basolateral membrane by limiting endocytic traffic (Perego et al., 1999
; Straight et al., 2001
; Olsen et al., 2002
; Shelly et al., 2003
), it is still uncertain if this function is carried out at the plasmalemma or within endosomes or both. Consequently, TIP-1 could disrupt any of basolateral membrane stabilization mechanisms that that have been attributed to mLin-7, including altering plasmalemma retention (Perego et al., 1999
) or active recycling in the postendocytic pathway (Straight et al., 2001
). Previous studies demonstrated that unrelated PDZ scaffolding proteins, NHERF (Cao et al., 1999
) and syntenin (Zimmermann et al., 2005
), influence surface stability of their binding targets by augmenting endocytic recycling. Importantly, the ability of these PDZ proteins to affect endocytic turnover depends on the presence of additional interaction modules that link the PDZ protein/target complex to cellular machinery or signaling molecules. For instance, expression of a syntenin mutant, lacking its PIP2-interaction site, causes syndecan, a type II PDZ-binding target of syntenin, to accumulate within engorged recycling endosomes (Zimmermann et al., 2005
), similar to the effect of TIP-1 expression on Kir 2.3 localization.
TIP-1 is also poised to disrupt PDZ association with the dystrophin-associated protein complex (DPC), the other major basolateral membrane PDZ protein scaffold. The complex consists of dystroglycans,
-dystrobrevin and utrophin, and the PDZ protein,
2-syntrophin (Kachinsky et al., 1999
). Syntrophin protein contains a type I PDZ-binding domain and additional domains that are required for utrophin binding. According to Kachinsky et al., steady state localization of
2-syntrophin at the basolateral membrane is dependent on utrophin binding. Because utrophin can simultaneously associate indirectly with laminin in the extracellular matrix via the dystroglycans (James et al., 2000
) and can bind directly to the actin cytoskeleton (Keep et al., 1999
), it is poised to provide a secure anchoring point for syntrophin at the basolateral membrane. Importantly, the association of syntrophin with utrophin and the basolateral membrane occurs independently of the syntrophin PDZ domain (Kachinsky et al., 1999
). This leaves the PDZ domain free to interact with other cell components containing a type I PDZ ligand motif, such as Kir 2 channel proteins (Leonoudakis et al., 2004a
). Analysis of currently known TIP-1binding partners suggests a modified type I PDZ consensus binding motif of R(D/E)(S/T)X(V/L/I)-COOH, matching the preferred ligands for the syntrophin PDZ domain (Wiedemann et al., 2004
). Thus, TIP-1 should disrupt association of type I PDZ ligands, such as Kir 2.3, to the syntrophin/DPC complex, similar to what we have observed with the mLin-7/CASK scaffold.
Our observations are most consistent with TIP-1 directly uncoupling basolateral PDZ scaffolding protein targets, such as Kir 2.3, in collecting duct principal cells, yet, it is presently unknown if TIP-1 may have different functions in other renal epithelial cell types or other tissues. For example, our observation that TIP-1 localizes to both the cytoplasm and the apical membrane in intercalated cells of the renal cortical collecting duct suggests that TIP-1 may have additional activities or even different mechanisms of negative regulation. Considering that formation of PDZ protein scaffolding networks, such as the apical membrane-associated NHERF1 protein complex (Fouassier et al., 2000
), can depend on PDZPDZ domain interactions, it will be important to determine if TIP-1 might also negatively regulate PDZ scaffolds by binding to and blocking PDZPDZ domain interactions.
It also remains unclear how many other additional type I PDZ functions could be negatively controlled by TIP-1. Only five other TIP-1binding partners have been described: the Rho-activator rhotekin (Reynaud et al., 2000
), glutaminase (Olalla et al., 2001
),
-catenin (Kanamori et al., 2003
), and the viral oncoproteins HTLV-1 Tax (Rousset et al., 1998
) and HPV16 E6 (Hampson et al., 2004
). Significantly, two of them,
-catenin (Perego et al., 2000
; Kanamori et al., 2003
) and the HTLV-1 oncoprotein Tax (Rousset et al., 1998
), are also mLin-7binding partners. At present, in is not know if TIP-1 actually antagonizes functions of these target proteins that ordinarily depend on mLin-7 interaction. In fact, the observation that TIP-1 suppresses the transcriptional activity of the cytoplasmic pool of
-catenin (Kanamori et al., 2003
) suggests that TIP-1 has negative regulatory activities beyond uncoupling scaffold complexes. On the basis of this previous report and our own observations of TIP-1 as a natural PDZ scaffold antagonist, we hypothesize that TIP-1 not only functions to prevent
-catenin from interacting with mLin-7, but that TIP-1 caps the C-terminal tail of
-catenin so as to prevent formation of the C-terminal fold-back conformation that is important for nuclear signaling (Gottardi and Gumbeiner, 2004
). Our model would offer an explanation for the transcriptionally inactive pool of cytoplasmic
-catenin that is also unable to associate with mLin-7/cadherin adhesive complexes (Gottardi et al., 2001
). Obviously, further studies will be required to determine if TIP-1 does function as a dual-inhibitory
-cateninsequestering factor.
In summary, TIP-1 represents a departure from classical PDZ protein structure because it contains only a single proteinprotein interaction motif and appears to lack endogenous membranetargeting information. Binding of TIP-1 antagonizes the surface membrane stabilization provided by association of a target protein with the basolateral membrane PDZ scaffolds and represents a novel means of regulating the surface density of membrane proteins containing a type I PDZ ligand motif.
| ACKNOWLEDGMENTS |
|---|
| Footnotes |
|---|
This article was published online ahead of print in MBC in Press (http://www.molbiolcell.org/cgi/doi/10.1091/mbc.E06-02-0129) on July 19, 2006.
* These authors contributed equally to this work. ![]()
Address correspondence to: Paul A. Welling (pwelling{at}umaryland.edu)
Abbreviations used: bHLH, basis helix-loop-helix; DPBS-M, Dulbecco's phosphate-buffered saline with 1 mM MgCl2; DPC, dystrophin-associated protein complex; mGluR, metabotropic glutamate receptor; mLin-7, mammalian Lin-7; TIP-1, Tax Interacting Protein-1.
| REFERENCES |
|---|
|
|
|---|
Borg, J. P., Straight, S. W., Kaech, S. M., de Taddeo-Borg, M., Kroon, D. E., Karnak, D., Turner, R. S., Kim, S. K., Margolis, B. (1998a). Identification of an evolutionarily conserved heterotrimeric protein complex involved in protein targeting. J. Biol. Chem 273, 3163331636.
Brone, B. and Eggermont, J. (2005). PDZ proteins retain and regulate membrane transporters in polarized epithelial cell membranes. Am. J. Physiol. Cell Physiol 288, C20C29.
Butz, S., Okamoto, M., Sudhof, T. C. (1998). A. tripartite protein complex with the potential to couple synaptic vesicle exocytosis to cell adhesion in brain. Cell 94, 773782.[CrossRef][Medline]
Cao, T. T., Deacon, H. W., Reczek, D., Bretscher, A., von Zastrow, M. (1999). A kinase-regulated PDZ-domain interaction controls endocytic sorting of the
2-adrenergic receptor. Nature 401, 286290.[CrossRef][Medline]
Campo, C., Mason, A., Maouyo, D., Olsen, O., Yoo, D., Welling, P. A. (2005). Molecular mechanisms of membrane polarity in renal epithelial cells. Rev. Physiol. Biochem. Pharmacol 153, 4799.[CrossRef][Medline]
Casanova, J. E., Wang, X., Kumar, R., Bhartur, S. G., Navarre, J., Woodrum, J. E., Altschuler, Y., Ray, G. S., Goldenring, J. R. (1999). Association of Rab25 and Rab11a with the apical recycling system of polarized Madin-Darby canine kidney cells. Mol. Biol. Cell 10, 4761.
Cohen, A. R., Woods, D. F., Marfatia, S. M., Walther, Z., Chishti, A. H., Anderson, J. M., Wood, D. F. W. (1998). Human CASK/LIN-2 binds syndecan-2 and protein 4.1 and localizes to the basolateral membrane of epithelial cells. J. Cell Biol 142, 129138.
Doerks, T., Bork, P., Kamberov, E., Makarova, O., Muecke, S., Margolis, B. (2000). L27, a novel heterodimerization domain in receptor targeting proteins Lin-2 and Lin-7. Trends Biochem. Sci 25, 317338.[CrossRef][Medline]
Doyle, D. A., Lee, A., Lewis, J., Kim, E., Sheng, M., MacKinnon, R. (1996). Crystal structures of a complexed and peptide-free membrane protein-binding domain: molecular basis of peptide recognition by PDZ. Cell 85, 10671076.[CrossRef][Medline]
Fouassier, L., Yun, C. C., Fitz, J. G., Doctor, R. B. (2000). Evidence for ezrin-radixin-moesin-binding phosphoprotein 50 (EBP50) self-association through PDZ-PDZ interactions. J. Biol. Chem 275, 2503925045.
Feng, W., Long, J. F., Fan, J. S., Suetake, T., Zhang, M. (2004). The tetrameric L27 domain complex as an organization platform for supramolecular assemblies. Nat. Struct. Mol. Biol 11, 475480.[CrossRef][Medline]
Golemis, E. A. and Khazak, V. (1997). Alternative yeast two-hybrid systems. The interaction trap and interaction mating. Methods Mol. Biol 63, 197218.
Gottardi, C. J., Wong, E., Gumbiner, B. M. (2001). E-cadherin suppresses cellular transformation by inhibiting beta-catenin signaling in an adhesion-independent manner. J. Cell Biol 153, 510491060.
Gottardi, C. J. and Gumbiner, B. M. (2004). Distinct molecular forms of beta-catenin are targeted to adhesive or transcriptional complexes. J. Cell Biol 167, 2339349.
Gyuris, J., Golemis, E. A., Chertkov, H., Brent, R. (1993). Cdi, a human G1 and S phase protein phosphatase that associates with Cdk2. Cell 75, 791803.[CrossRef][Medline]
Hampson, L., Li, C., Oliver, A. W., Kitchener, H. C., Hampson, I. N. (2004). The PDZ protein Tip-1 is a gain of function target of the HPV16 E6 oncoprotein. J. Oncol 25, 12491256.
Hata, Y., Slaughter, C. A., Sudhof, T. C. (1993). Synaptic vesicle fusion complex contains unc-18 homologue bound to syntaxin. Nature 366, 347351.[CrossRef][Medline]
Henkel, J. R., Apodaca, G., Altschuler, Y., Hardy, S., Weisz, O. A. (1998). Selective perturbation of apical membrane traffic by expression of influenza M2, an acid-activated ion channel, in polarized madin-darby canine kidney cells. Mol. Biol. Cell 9, 24772490.
James, M., Nuttall, A., Ilsley, J. L., Ottersbach, K., Tinsley, J. M., Sudol, M., Winder, S. J. (2000). Adhesion-dependent tyrosine phosphorylation of (beta)-dystroglycan regulates its interaction with utrophin. J. Cell Sci 113, Pt 1017171726.[Abstract]
Kachinsky, A. M., Froehner, S. C., Milgram, S. L. (1999). A PDZ-containing scaffold related to the dystrophin complex at the basolateral membrane of epithelial cells. J. Cell Biol 145, 391402.
Kaech, S. M., Whitfield, C. W., Kim, S. K. (1998). The LIN-2/LIN-7/LIN-10 complex mediates basolateral membrane localization of the C. elegans EGF receptor LET-23 in vulval epithelial cells. Cell 94, 761771.[CrossRef][Medline]
Kanamori, M., Sandy, P., Marzinotto, S., Benetti, R., Kai, C., Hayashizaki, Y., Schneider, C., Suzuki, H. (2003). The PDZ protein tax-interacting protein-1 inhibits beta-catenin transcriptional activity and growth of colorectal cancer cells. J. Biol. Chem 278, 3875838764.
Karnak, D., Lee, S., Margolis, B. (2002). Identification of multiple binding partners for the amino-terminal domain of synapse-associated protein 97. J. Biol. Chem 277, 4673046735.
Keep, N. H., Winder, S. J., Moores, C. A., Walke, S., Norwood, F. L., Kendrick-Jones, J. (1999). Crystal structure of the actin-binding region of utrophin reveals a head-to-tail dimer. Structure Fold Des 7, 15391546.[Medline]
Khosla, S. (2001). Minireview: the OPG/RANKL/RANK system. Endocrinology 142, 50505055.
Kim, E. and Sheng, M. (2004). PDZ domain proteins of synapses. Nat. Rev. Neurosci 5, 771781.[CrossRef][Medline]
Kroiher, M., Miller, M. A., Steele, R. E. (2001). Deceiving appearances: signaling by "dead" and "fractured" receptor protein-tyrosine kinases. Bioessays 23, 6976.[CrossRef][Medline]
Le Maout, S., Brejon, M., Merot, J., Welling, P. A. (1997). Polarized expression of an epitope tagged CCD Kir Channel, CCD-IRK3, in MDCK cells. Proc. Natl. Acad. Sci. USA 94, 1332913334.
Le Maout, S., Welling, P. A., Brejon, M., Olsen, O., Merot, J. (2001). Basolateral membrane expression of a K+ channel, Kir 2.3, is directed by a cytoplasmic COOH-terminal domain. Proc. Natl. Acad. Sci. USA 98, 1047510480.
Lee, S., Fan, S., Makarova, O., Straight, S., Margolis, B. (2002). A novel and conserved protein-protein interaction domain of mammalian Lin-2/CASK binds and recruits SAP97 to the lateral surface of epithelia. Mol. Cell. Biol 22, 17781791.
Leonoudakis, D., Conti, L. R., Anderson, S., Radeke, C. M., McGuire, L. M., Adams, M. E., Froehner, S. C., Yates, J. R. 3rd, Vandenberg, C. A. (2004a). Protein trafficking and anchoring complexes revealed by proteomic analysis of inward rectifier potassium channel (Kir2.x)-associated proteins. J. Biol. Chem 279, 2233122346.
Leonoudakis, D., Conti, L. R., Radeke, C. M., McGuire, L. M., Vandenberg, C. A. (2004b). A multiprotein trafficking complex composed of SAP97, CASK, Veli, and Mint1 is associated with inward rectifier Kir2 potassium channels. J. Biol. Chem 279, 1905119063.
Leonoudakis, D., Mailliard, W., Wingerd, K., Clegg, D., Vandenberg, C. (2001). Inward rectifier potassium channel Kir2.2 is associated with synapse-associated protein SAP97. J. Cell Sci 114, 987998.[Abstract]
Li, Y., Karnak, D., Demeler, B., Margolis, B., Lavie, A. (2004). Structural basis for L27 domain-mediated assembly of signaling and cell polarity complexes. EMBO J 23, 27232733.[CrossRef][Medline]
Mantovani, A., Locati, M., Polentarutti, N., Vecchi, A., Garlanda, C. (2004). Extracellular and intracellular decoys in the tuning of inflammatory cytokines and Toll-like receptors: the new entry TIR8/SIGIRR. J. Leukoc. Biol 75, 738742.
Mendelsohn, A. R. and Brent, R. (1994). Applications of interaction traps/two-hybrid systems to biotechnology research. Curr. Opin. Biotechnol 5, 482486.[CrossRef][Medline]
Olalla, L., Aledo, J. C., Bannenberg, G., Marquez, J. (2001). The C-terminus of human glutaminase L mediates association with PDZ domain-containing proteins. FEBS Lett 488, 116122.[CrossRef][Medline]
Olsen, O., Liu, H., Wade, J. B., Merot, J., Welling, P. A. (2002). Basolateral membrane expression of the Kir 2.3 channel is coordinated by PDZ interaction with Lin-7/CASK complex. Am. J. Physiol. Cell Physiol 282, C183C195.
Olsen, O., Wade, J. B., Morin, N., Bredt, D. S., Welling, P. A. (2005). Differential localization of mammalianLin-7 (MALS/Veli) PDZ proteins in the kidney. Am. J. Physiol. Renal Physiol 288, F345F352.
Perego, C., Vanoni, C., Massari, S., Longhi, R., Pietrini, G. (2000). Mammalian LIN-7 PDZ proteins associate with beta-catenin at the cell-cell junctions of epithelia and neurons. EMBO J 19, 39783989.[CrossRef][Medline]
Perego, C., Vanoni, C., Villa, A., Longhi, R., Kaech, S. M., Frohli, E., Hajnal, A., Kim, S. K., Pietrini, G. (1999). PDZ-mediated interactions retain the epithelial GABA transporter on the basolateral surface of polarized epithelial cells. EMBO J 18, 23842393.[CrossRef][Medline]
Reynaud, C., Fabre, S., Jalinot, P. (2000). The PDZ protein TIP-1 interacts with the Rho effector rhotekin and is involved in Rho signaling to the serum response element. J. Biol. Chem 275, 3396233968.
Reynolds, A., Lundblad, V., Dorris, D., Keaveney, M. (1997). Yeast vectors and assays for expression of cloned genes. In: Current Protocols in Molecular Biology, ed. F. M. Ausubel, R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, K. Struhl. Boston: John Wiley & Sons, 13.6.113.6.6.
Roh, M. H., Makarova, O., Liu, C. J., Shin, K., Lee, S., Laurinec, S., Goyal, M., Wiggins, R., Margolis, B. (2002). The Maguk protein, Pals1, functions as an adapter, linking mammalian homologues of Crumbs and Discs Lost. J. Cell Biol 157, 161172.
Rongo, C., Whitfield, C. W., Rodal, A., Kim, S. K., Kaplan, J. M. (1998). LIN-10 is a shared component of the polarized protein localization pathways in neurons and epithelia. Cell 94, 751759.[CrossRef][Medline]
Rousset, R., Fabre, S., Desbois, C., Bantignies, F., Jalinot, P. (1998). The C-terminus of the HTLV-1 Tax oncoprotein mediates interaction with the PDZ domain of cellular proteins. Oncogene 16, 643654.[CrossRef][Medline]
Setou, M., Nakagawa, T., Seog, D. H., Hirokawa, N. (2000). Kinesin superfamily motor protein KIF17 and mLin-10 in NMDA receptor-containing vesicle transport. Science 288, 17961802.
Sheff, D. R., Daro, E. A., Hull, M., Mellman, I. (1999). The receptor recycling pathway contains two distinct populations of early endosomes with different sorting functions. J. Cell Biol 145, 123139.
Shelly, M., Mosesson, Y., Citri, A., Lavi, S., Zwang, Y., Melamed-Book, N., Aroeti, B., Yarden, Y. (2003). Polar expression of ErbB-2/HER2 in epithelia. Bimodal regulation by Lin-7. Dev. Cell 5, 475486.[CrossRef][Medline]
Simske, J. S., Kaech, S. M., Harp, S. A., Kim, S. K. (1996). LET-23 receptor localization by the cell junction protein LIN-7 during C. elegans vulval induction. Cell 85, 195204.[CrossRef][Medline]
Songyang, Z., Fanning, A. S., Fu, C., Xu, J., Marfatia, S. M., Chishti, A. H., Chan, A. C., Anderson, J. M., Cantley, L. C. (1997). Recognition of unique carboxyl-terminal motifs by distinct PDZ domains. Science 275, 7377.
Straight, S. W., Chen, L., Karnak, D., Margolis, B. (2001). Interaction with mLin-7 alters the targeting of endocytosed transmembrane proteins in mammalian epithelial cells. Mol. Biol. Cell 12, 13291340.
Straight, S. W., Karnak, D., Borg, J. P., Kamberov, E., Dare, H., Margolis, B., Wade, J. B. (2000). mLin-7 is localized to the basolateral surface of renal epithelia via its NH(2) terminus. Am. J. Physiol. Renal. Physiol 278, F464F475.
Wang, X., Kumar, R., Navarre, J., Casanova, J. E., Goldenring, J. R. (2000). Regulation of vesicle trafficking in madin-darby canine kidney cells by Rab11a and Rab25. J. Biol. Chem 275, 2913829146.
Wiedemann, U., Boisguerin, P., Leben, R., Leitner, D., Krause, G., Moelling, K., Volkmer-Engert, R., Oschkinat, H. (2004). Quantification of PDZ domain specificity, prediction of ligand affinity and rational design of super-binding peptides. J. Mol. Biol 343, 703718.[CrossRef][Medline]
Xiao, B., Tu, J. C., Petralia, R. S., Yuan, J. P., Doan, A., Breder, C. D., Ruggiero, A., Lanahan, A. A., Wenthold, R. J., Worley, P. F. (1998). Homer regulates the association of group 1 metabotropic glutamate receptors with multivalent complexes of homer-related, synaptic proteins. Neuron 21, 707716.[CrossRef][Medline]
Yokota, Y. and Mori, S. (2002). Role of Id family proteins in growth control. J. Cell. Physiol 190, 2128.[CrossRef][Medline]
Zimmermann, P., Zhang, Z., Degeest, G., Mortier, E., Leenaerts, I., Coomans, C., Schulz, J., N'Kuli, F., Courtoy, P. J., David, G. (2005). Syndecan recycling is controlled by syntenin-PIP2 interaction with ARF6. Dev. Cell 9, 377388.[CrossRef][Medline]
This article has been cited by other articles:
![]() |
A. Sindic, C. Huang, A.-P. Chen, Y. Ding, W. A. Miller-Little, D. Che, M. F. Romero, and R. T. Miller MUPP1 complexes renal K+ channels to alter cell surface expression and whole cell currents Am J Physiol Renal Physiol, July 1, 2009; 297(1): F36 - F45. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Mason, B. E. Jacobs, and P. A. Welling AP-2-dependent Internalization of Potassium Channel Kir2.3 Is Driven by a Novel Di-hydrophobic Signal J. Biol. Chem., March 7, 2008; 283(10): 5973 - 5984. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Alewine, B.-y. Kim, V. Hegde, and P. A. Welling Lin-7 targets the Kir 2.3 channel on the basolateral membrane via a L27 domain interaction with CASK Am J Physiol Cell Physiol, December 1, 2007; 293(6): C1733 - C1741. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Yi, R. S. Petralia, Z. Fu, C. C. Swanwick, Y.-X. Wang, K. Prybylowski, N. Sans, S. Vicini, and R. J. Wenthold The Role of the PDZ Protein GIPC in Regulating NMDA Receptor Trafficking J. Neurosci., October 24, 2007; 27(43): 11663 - 11675. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||